CHSCP CHS (CHSCP) Insider Trading, Ownership & Congress Trades
Wholesale & Retail · Wholesale-farm product raw materials · CIK 0000823277
SEC filings
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
1
13F, latest reported quarter
CHS insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
No insider purchases or sales are on record for CHS INC in the period covered. Source: SEC Form 4 filings, as of 2026-10-28.
Insider
Filed
Shares
Value
Since filing
Context
- First Form 4 purchase or sale (code P or S) here by this insider on our record.
- The trade is 100.0% of the 3,000 shares held after it.
- No other insider sold within 30 days.
- 1 fund added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Farrell Mark L sold about $88.5K of CHSCP on Jul 26, 2022, the largest insider sale at the company on our record; 1 fund added in the latest 13F quarter.Context
- First Form 4 purchase or sale (code P or S) here by this insider on our record.
- No other insider sold within 30 days.
- 1 fund added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Erickson Larry Jon sold about $9.2K of CHSCP on Nov 10, 2021, the largest insider sale at the company on our record; 1 fund added in the latest 13F quarter.2 transactions on record · a thin record, read with care
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Seven facts, ranked against the sector ·
Rank is not a forecast
Insiders
no insider buys or sells on file
Congress
no House purchase disclosed in the last 12 months
Funds
1 fund bought in last quarter
Revenue
-9.7% year over year
below 81% of Wholesale & Retail
Margin
1.7% net margin
more than 54% of Wholesale & Retail
Buybacks
no share repurchases reported
Short interest
1.0 days to cover · settled 2026-09-30
What changed in the last 30 days
Nothing new filed in the last 30 days
Watch CHSCP
A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.
The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
-6.4%12M
Indexed to 100, dividend-adjusted, not a price chart.
When a name files heavily, the largest trades are drawn first.
Who owns CHSCP: institutional holders (13F)
13F holdings, latest reported quarter
24,229 sh
$584.9K
12,922 sh
$318.8K
$22.3K
Congress trades in CHSCP
No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.
Activist and 5% holders (13D/13G)
No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.
CHSCP planned insider sales (Form 144)
No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
CHSCP mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Global X Variable Rate Preferred ETF
$7.5M position · as of 2026-05-31
2.5%
Nuveen Flexible Income Fund
$9.6M position · as of 2026-05-31
1.2%
Multi-Asset Diversified Income Index Fund
$2.9M position · as of 2026-06-30
0.7%
VanEck Preferred Securities ex Financials ETF
$17.2M position · as of 2026-06-30
0.7%
VanEck Preferred Securities ex Financials ETF
$15.6M position · as of 2026-06-30
0.6%
VanEck Preferred Securities ex Financials ETF
$10.8M position · as of 2026-06-30
0.4%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
The record shows 1 funds added last quarter. Each figure is a federal filing, dated the day it went public.
CHSCP financials
Revenue growth
-9.7%
XBRL, annual
Net margin
1.7%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$37.4B
four quarters, 2025-06-01 to 2026-05-31
Revenue, TTM CHSCP
| FY Aug 2025 | $35.5B |
| FY Aug 2024 | $39.3B |
| FY Aug 2023 | $45.6B |
| FY Aug 2022 | $47.8B |
| FY Aug 2021 | $38.4B |
| May 2026 | $11.6B |
| Feb 2026 | $8.4B |
| Nov 2025 | $8.9B |
| Aug 2025 | $8.6B |
| May 2025 | $9.8B |
| Feb 2025 | $7.8B |
| Nov 2024 | $9.3B |
| Aug 2024 | $9.2B |
At each fiscal year end
Single quarter
Net margin, TTM
+1.5%
net income over revenue, 2025-06-01 to 2026-05-31
Net margin, TTM CHSCP
| FY Aug 2025 | +1.7% |
| FY Aug 2024 | +2.8% |
| FY Aug 2023 | +4.2% |
| FY Aug 2022 | +3.5% |
| FY Aug 2021 | +1.4% |
| May 2026 | +2.3% |
| Feb 2026 | -1.8% |
| Nov 2025 | +2.9% |
| Aug 2025 | +2.3% |
| May 2025 | +2.4% |
| Feb 2025 | -1.0% |
| Nov 2024 | +2.6% |
| Aug 2024 | +1.2% |
At each fiscal year end
Single quarter
Free cash flow, TTM
$932.9M
operating cash flow minus capex, 2025-06-01 to 2026-05-31
Free cash flow, TTM CHSCP
| FY Aug 2025 | -$92.8M |
| FY Aug 2024 | $464.1M |
| FY Aug 2023 | $2.7B |
| FY Aug 2022 | $1.6B |
| FY Aug 2021 | $440.0M |
| May 2026 | $984.7M |
| Feb 2026 | -$674.0M |
| Nov 2025 | -$453.8M |
| Aug 2025 | $1.1B |
| May 2025 | $520.6M |
| Feb 2025 | -$1.2B |
| Nov 2024 | -$486.6M |
| Aug 2024 | $845.8M |
At each fiscal year end
Single quarter
Debt to equity
0.19x
long-term 2026-05-31 plus current 2025-11-30 (6 months older than the period end); equity 2026-05-31
Debt to equity CHSCP
| FY Aug 2025 | 0.17x |
| FY Aug 2024 | 0.20x |
| FY Aug 2023 | 0.17x |
| FY Aug 2022 | 0.21x |
| FY Aug 2021 | 0.18x |
| May 2026 | 0.19x |
| Feb 2026 | 0.19x |
| Nov 2025 | 0.16x |
| Aug 2025 | 0.17x |
| May 2025 | 0.19x |
| Feb 2025 | 0.19x |
| Nov 2024 | 0.20x |
| Aug 2024 | 0.20x |
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.71x
TTM operating cash flow over long-term 2026-05-31 plus current 2025-11-30 (6 months older than the period end)
Cash flow to debt CHSCP
| FY Aug 2025 | 0.35x |
| FY Aug 2024 | 0.59x |
| FY Aug 2023 | 1.80x |
| FY Aug 2022 | 0.99x |
| FY Aug 2021 | 0.47x |
| May 2026 | 0.71x |
| Feb 2026 | 0.51x |
| Nov 2025 | 0.32x |
| Aug 2025 | 0.35x |
| May 2025 | 0.24x |
| Feb 2025 | 0.17x |
| Nov 2024 | 0.52x |
| Aug 2024 | 0.59x |
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+5.3%
TTM net income over average of 2025-05-31 and 2026-05-31
Return on equity CHSCP
| FY Aug 2025 | +5.5% |
| FY Aug 2024 | +10.4% |
| FY Aug 2023 | +19.1% |
| FY Aug 2022 | +18.2% |
| FY Aug 2021 | +6.2% |
| May 2026 | +5.3% |
| Feb 2026 | +5.0% |
| Nov 2025 | +5.6% |
| Aug 2025 | +5.5% |
| May 2025 | +4.7% |
| Feb 2025 | +5.4% |
| Nov 2024 | +7.7% |
| Aug 2024 | +10.4% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+2.9%
TTM net income over average of 2025-05-31 and 2026-05-31
Return on assets CHSCP
| FY Aug 2025 | +3.2% |
| FY Aug 2024 | +5.9% |
| FY Aug 2023 | +10.1% |
| FY Aug 2022 | +9.2% |
| FY Aug 2021 | +3.3% |
| May 2026 | +2.9% |
| Feb 2026 | +2.6% |
| Nov 2025 | +3.0% |
| Aug 2025 | +3.2% |
| May 2025 | +2.7% |
| Feb 2025 | +2.9% |
| Nov 2024 | +4.1% |
| Aug 2024 | +5.9% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
effective tax rate -1%, not meaningful
Return on invested capital CHSCP
| FY Aug 2025 | +0.7% |
| FY Aug 2024 | n/a |
| FY Aug 2023 | +12.1% |
| FY Aug 2022 | +9.9% |
| FY Aug 2021 | n/a |
| May 2026 | n/a |
| Feb 2026 | +0.0% |
| Nov 2025 | +0.6% |
| Aug 2025 | +0.7% |
| May 2025 | +0.1% |
| Feb 2025 | n/a |
| Nov 2024 | +2.7% |
| Aug 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+0.3%
operating income (EBIT proxy) over average of 2025-05-31 and 2026-05-31 minus current liabilities
Return on capital employed CHSCP
| FY Aug 2025 | +0.7% |
| FY Aug 2024 | +4.4% |
| FY Aug 2023 | +10.8% |
| FY Aug 2022 | +9.8% |
| FY Aug 2021 | +1.8% |
| May 2026 | +0.3% |
| Feb 2026 | +0.0% |
| Nov 2025 | +0.5% |
| Aug 2025 | +0.7% |
| May 2025 | +0.1% |
| Feb 2025 | +0.7% |
| Nov 2024 | +2.4% |
| Aug 2024 | +4.4% |
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
n/a
fewer than four consecutive quarters of diluted EPS
P/E, trailing CHSCP
| FY Aug 2025 | n/a |
| FY Aug 2024 | n/a |
| FY Aug 2023 | n/a |
| FY Aug 2022 | n/a |
| FY Aug 2021 | n/a |
| May 2026 | n/a |
| Feb 2026 | n/a |
| Nov 2025 | n/a |
| Aug 2025 | n/a |
| May 2025 | n/a |
| Feb 2025 | n/a |
| Nov 2024 | n/a |
| Aug 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
n/a
no share count filed
Enterprise value CHSCP
| FY Aug 2025 | n/a |
| FY Aug 2024 | n/a |
| FY Aug 2023 | n/a |
| FY Aug 2022 | n/a |
| FY Aug 2021 | n/a |
| May 2026 | n/a |
| Feb 2026 | n/a |
| Nov 2025 | n/a |
| Aug 2025 | n/a |
| May 2025 | n/a |
| Feb 2025 | n/a |
| Nov 2024 | n/a |
| Aug 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
n/a
no share count filed
FCF yield CHSCP
| FY Aug 2025 | n/a |
| FY Aug 2024 | n/a |
| FY Aug 2023 | n/a |
| FY Aug 2022 | n/a |
| FY Aug 2021 | n/a |
| May 2026 | n/a |
| Feb 2026 | n/a |
| Nov 2025 | n/a |
| Aug 2025 | n/a |
| May 2025 | n/a |
| Feb 2025 | n/a |
| Nov 2024 | n/a |
| Aug 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
fewer than four consecutive quarters of diluted EPS
PEG, trailing CHSCP
| FY Aug 2025 | n/a |
| FY Aug 2024 | n/a |
| FY Aug 2023 | n/a |
| FY Aug 2022 | n/a |
| FY Aug 2021 | n/a |
| May 2026 | n/a |
| Feb 2026 | n/a |
| Nov 2025 | n/a |
| Aug 2025 | n/a |
| May 2025 | n/a |
| Feb 2025 | n/a |
| Nov 2024 | n/a |
| Aug 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-27. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
| 2025-08 | 2024-08 | 2024-04 | 2023-08 | |
|---|---|---|---|---|
| Revenue | $35.5B | $39.3B | n/a | $45.6B |
| Gross profit | $1.1B | $1.8B | n/a | $2.4B |
| Operating income | $90.8M | $584.4M | n/a | $1.3B |
| Net income | $597.9M | $1.1B | n/a | $1.9B |
| Operating cash flow | $635.8M | $1.3B | n/a | $3.3B |
| Cash | $327.8M | $794.9M | n/a | $1.8B |
| Long-term debt | $1.7B | $1.8B | $700.0M | $1.8B |
SEC XBRL, fiscal years, as known on 2026-10-28
CHSCP Stock Sonar score 4/7 axes
Find similar shapesCompareCHSCP ranks highest on financial health (67th percentile) and risk and compliance (66th), and lowest on growth (19th), among Wholesale & Retail peers.
4 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
